kt 5823 has been researched along with 7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1,3-dimethylxanthine in 1 studies
| Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1,3-dimethylxanthine) | Trials (7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1,3-dimethylxanthine) | Recent Studies (post-2010) (7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1,3-dimethylxanthine) |
|---|---|---|---|---|---|
| 317 | 0 | 59 | 7 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, IJ; Liou, SF; Liu, CP; Wu, BN; Yeh, JL | 1 |
1 other study(ies) available for kt 5823 and 7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1,3-dimethylxanthine
| Article | Year |
|---|---|
Phosphodiesterase inhibitor KMUP-3 displays cardioprotection via protein kinase G and increases cardiac output via G-protein-coupled receptor agonist activity and Ca(2+) sensitization.
Topics: Animals; Blood Pressure; Calcium Signaling; Carbazoles; Cardiac Output; Cardiotonic Agents; Cell Line; Cyclic GMP-Dependent Protein Kinases; Drug Evaluation, Preclinical; Female; Guinea Pigs; Heart Atria; Male; Phosphodiesterase Inhibitors; Piperidines; Protein Transport; Rats, Wistar; Receptors, G-Protein-Coupled; Ventricular Pressure; Xanthines | 2016 |